These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 37280062)

  • 1. Veno-arterial extracorporeal membrane oxygenation for circulatory failure in COVID-19 patients: insights from the ECMOSARS registry.
    Anselmi A; Mansour A; Para M; Mongardon N; Porto A; Guihaire J; Morgant MC; Pozzi M; Cholley B; Falcoz PE; Gaudard P; Lebreton G; Labaste F; Barbanti C; Fouquet O; Chocron S; Mottard N; Esvan M; Fougerou-Leurent C; Flecher E; Vincentelli A; Nesseler N;
    Eur J Cardiothorac Surg; 2023 Sep; 64(3):. PubMed ID: 37280062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support.
    Sun T; Guy A; Sidhu A; Finlayson G; Grunau B; Ding L; Harle S; Dewar L; Cook R; Kanji HD
    J Crit Care; 2018 Apr; 44():31-38. PubMed ID: 29040883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Outcomes of COVID-19 Patients Supported by Venoarterial or Veno-Arterial-Venous Extracorporeal Membrane Oxygenation.
    Haroun MW; Patel SR; Sims DB; Jorde UP; Goldstein DJ; Saeed O
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2935-2941. PubMed ID: 35249832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of veno-arterio-venous extracorporeal membrane oxygenation in patients with critical respiratory failure combined with refractory shock].
    Li Y; Li XY; Tang X; Wang R; Zhang CY; Wang SQ; Yuan X; Wang L; Tong ZH; Sun B
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun; 46(6):565-571. PubMed ID: 37278170
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 6. Veno-arterial extracorporeal membrane oxygenation for drug intoxications: A single center, 14-year experience.
    Pozzi M; Buzzi R; Hayek A; Portran P; Schweizer R; Fellahi JL; Armoiry X; Flagiello M; Grinberg D; Obadia JF
    J Card Surg; 2022 Jun; 37(6):1512-1519. PubMed ID: 35353389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
    Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
    Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-arterial ECMO ventricular assistance as a direct bridge to heart transplant: A single center experience in a low-middle income country.
    Burgos LM; Chicote FS; Vrancic M; Seoane L; Ballari FN; Baro Vila RC; De Bortoli MA; Furmento JF; Costabel JP; Piccinini F; Navia D; Espinoza J; Diez M
    Clin Transplant; 2024 Jun; 38(6):e15334. PubMed ID: 38864350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term and intermediate outcomes of cardiogenic shock and cardiac arrest patients supported by venoarterial extracorporeal membrane oxygenation.
    Vakil D; Soto C; D'Costa Z; Volk L; Kandasamy S; Iyer D; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2021 Oct; 16(1):290. PubMed ID: 34627305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initiation timing of veno-arterial extracorporeal membrane oxygenation].
    Li JJ; Luo XX; Huang XB
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1874-1877. PubMed ID: 35768382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Timing of Venoarterial-Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Patients Suffering From Refractory Cardiogenic Shock.
    Choi KH; Yang JH; Hong D; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Choi JH; Chung SR; Cho YH; Jeong DS; Sung K; Kim WS; Lee YT; Gwon HC
    Circ J; 2020 Aug; 84(9):1502-1510. PubMed ID: 32684541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venoarterial extracorporeal membrane oxygenation for cardiac support in human immunodeficiency virus-positive patients: a case report and review of a multicentre registry.
    Laraghy M; McCullough J; Gerrard J; Stroebel A; Winearls J
    J Cardiothorac Surg; 2023 Apr; 18(1):109. PubMed ID: 37029414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-cardiac arrest shock treated with veno-arterial extracorporeal membrane oxygenation: An observational study and propensity-score analysis.
    Bougouin W; Aissaoui N; Combes A; Deye N; Lamhaut L; Jost D; Maupain C; Beganton F; Bouglé A; Karam N; Dumas F; Marijon E; Jouven X; Cariou A;
    Resuscitation; 2017 Jan; 110():126-132. PubMed ID: 27865776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes With Peripheral Venoarterial Extracorporeal Membrane Oxygenation for Suspected Acute Myocarditis: 10-Year Experience From the Extracorporeal Life Support Organization Registry.
    Nunez JI; Grandin EW; Reyes-Castro T; Sabe M; Quintero P; Motiwala S; Fleming LM; Sriwattanakomen R; Ho JE; Kennedy K; Tonna JE; Garan AR
    Circ Heart Fail; 2023 Jul; 16(7):e010152. PubMed ID: 37345545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry.
    Smith M; Vukomanovic A; Brodie D; Thiagarajan R; Rycus P; Buscher H
    Crit Care; 2017 Mar; 21(1):45. PubMed ID: 28264702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Clinical Outcome After Early Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction.
    Szczanowicz L; Majunke N; de Waha-Thiele S; Tietz F; Schürer S; Kirsch K; Desch S; Thiele H; Sandri M
    J Invasive Cardiol; 2021 May; 33(5):E329-E335. PubMed ID: 33932279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score.
    Schiller P; Hellgren L; Vikholm P
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):329-337. PubMed ID: 30406678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of extracorporeal membrane oxygenation in the setting of postinfarction mechanical complications: outcome analysis of the Extracorporeal Life Support Organization Registry.
    Matteucci M; Fina D; Jiritano F; Meani P; Raffa GM; Kowalewski M; Aldobayyan I; Turkistani M; Beghi C; Lorusso R
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):369-374. PubMed ID: 32728712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary Use of Veno-Arterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Acute Coronary Syndrome.
    Negi SI; Sokolovic M; Koifman E; Kiramijyan S; Torguson R; Lindsay J; Ben-Dor I; Suddath W; Pichard A; Satler L; Waksman R
    J Invasive Cardiol; 2016 Feb; 28(2):52-7. PubMed ID: 26689415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.